JPWO2020050409A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020050409A5
JPWO2020050409A5 JP2021512830A JP2021512830A JPWO2020050409A5 JP WO2020050409 A5 JPWO2020050409 A5 JP WO2020050409A5 JP 2021512830 A JP2021512830 A JP 2021512830A JP 2021512830 A JP2021512830 A JP 2021512830A JP WO2020050409 A5 JPWO2020050409 A5 JP WO2020050409A5
Authority
JP
Japan
Prior art keywords
optionally substituted
ring
salt
halogen
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021512830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021536482A5 (https=
JP7448527B2 (ja
JP2021536482A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/035233 external-priority patent/WO2020050409A1/en
Publication of JP2021536482A publication Critical patent/JP2021536482A/ja
Publication of JPWO2020050409A5 publication Critical patent/JPWO2020050409A5/ja
Publication of JP2021536482A5 publication Critical patent/JP2021536482A5/ja
Application granted granted Critical
Publication of JP7448527B2 publication Critical patent/JP7448527B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021512830A 2018-09-07 2019-09-06 ヘテロ環式化合物 Active JP7448527B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018167488 2018-09-07
JP2018167488 2018-09-07
PCT/JP2019/035233 WO2020050409A1 (en) 2018-09-07 2019-09-06 Heterocyclic compound

Publications (4)

Publication Number Publication Date
JP2021536482A JP2021536482A (ja) 2021-12-27
JPWO2020050409A5 true JPWO2020050409A5 (https=) 2022-09-14
JP2021536482A5 JP2021536482A5 (https=) 2022-09-14
JP7448527B2 JP7448527B2 (ja) 2024-03-12

Family

ID=68063002

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021512830A Active JP7448527B2 (ja) 2018-09-07 2019-09-06 ヘテロ環式化合物

Country Status (12)

Country Link
US (2) US11932657B2 (https=)
EP (1) EP3847176A1 (https=)
JP (1) JP7448527B2 (https=)
KR (1) KR102810086B1 (https=)
CN (1) CN112654627A (https=)
AU (2) AU2019335968B2 (https=)
CA (1) CA3109610A1 (https=)
EA (1) EA202190654A1 (https=)
IL (1) IL280821B2 (https=)
SG (1) SG11202101963XA (https=)
TW (1) TWI854995B (https=)
WO (1) WO2020050409A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7448527B2 (ja) 2018-09-07 2024-03-12 大塚製薬株式会社 ヘテロ環式化合物
IL291322B2 (en) 2019-12-09 2026-02-01 Otsuka Pharma Co Ltd Acrylamide compounds
US20230279000A1 (en) 2020-02-26 2023-09-07 Jaguahr Therapeutics Pte Ltd Pyridopyrimidine derivatives useful in modulation of ahr signalling
CN114181212B (zh) * 2020-09-15 2023-06-06 山东轩竹医药科技有限公司 哒嗪酮类AhR抑制剂
CN115215720B (zh) * 2021-04-19 2023-08-22 中国科学院化学研究所 含薁单元的石墨烯纳米片段分子—薁并玉红省及其合成方法与应用
WO2022228399A1 (zh) * 2021-04-27 2022-11-03 山东轩竹医药科技有限公司 三并环类usp1抑制剂及其用途
WO2023033742A1 (en) * 2021-09-02 2023-03-09 Jaguahr Therapeutics Pte Ltd Compounds useful in modulation of ahr signalling
KR20240054994A (ko) * 2021-09-02 2024-04-26 재규어 테라퓨틱스 피티이 리미티드 AhR 시그널링의 조절에 유용한 화합물
WO2023033741A1 (en) * 2021-09-02 2023-03-09 Jaguahr Therapeutics Pte Ltd Compounds useful in modulation of ahr signalling
WO2024076300A1 (en) 2022-10-03 2024-04-11 Jaguahr Therapeutics Pte Ltd Compounds useful in modulation of ahr signalling
JP7527515B1 (ja) * 2022-10-29 2024-08-02 松本油脂製薬株式会社 弾性繊維用処理剤及びその利用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20100362A1 (es) 2008-10-30 2010-05-27 Irm Llc Derivados de purina que expanden las celulas madre hematopoyeticas
CN103313989B (zh) 2010-12-16 2016-05-04 霍夫曼-拉罗奇有限公司 三环pi3k抑制剂化合物和使用方法
WO2014138485A1 (en) * 2013-03-08 2014-09-12 Irm Llc Ex vivo production of platelets from hematopoietic stem cells and the product thereof
DK3312270T3 (da) 2015-06-16 2020-10-12 Univ Kyoto Fremgangsmåde til fremstilling af plader med høj ydeevne
WO2018195397A2 (en) * 2017-04-21 2018-10-25 Kyn Therapeutics Indole ahr inhibitors and uses thereof
WO2019167973A1 (en) 2018-03-01 2019-09-06 Kyoto University Cell cycle progression inhibitor
JP7448527B2 (ja) 2018-09-07 2024-03-12 大塚製薬株式会社 ヘテロ環式化合物
IL291322B2 (en) 2019-12-09 2026-02-01 Otsuka Pharma Co Ltd Acrylamide compounds
JP2022188761A (ja) 2021-06-09 2022-12-21 大塚製薬株式会社 窒素原子含有複素環化合物を用いる血小板産生方法

Similar Documents

Publication Publication Date Title
JP2021536482A5 (https=)
JPWO2020050409A5 (https=)
AU2007282949B2 (en) (3-amino-1,2,3,4-tetrahydro-9H-carbazol-9-YL)-acetic acid derivatives
TWI752155B (zh) 芳香烴受體(AhR)調節劑化合物
US6514968B1 (en) Aminoalkoxy carbazoles for the treatment of cns diseases
JPH10513442A (ja) 5−htレセプターアンタゴニストとしてのインドール誘導体
KR20100027950A (ko) 안트라센 유도체 및 이를 이용한 유기 전계 발광 소자
JP2010521515A5 (https=)
KR20090079134A (ko) 새로운 이미다졸 유도체 및 이를 이용한 유기전자소자
WO2017133655A1 (zh) 苯并噻嗪和苯并噻二嗪类化合物及制备和应用
CN104530014B (zh) 2‑氧代‑1,2‑二氢苯并[cd]吲哚‑6‑磺酰胺类化合物及其组合物和应用
CN115677696A (zh) 一种苯并萘啶衍生物的制备方法
ZA200306108B (en) Beta-carboline derivatives and its pharmaceutical use against depression and anxiety.
CN112358432B (zh) 一种吲哚类衍生物的合成方法
RU2016138800A (ru) Новый способ получения производных триазина, пиримидина и пиридина
JP2013540738A5 (https=)
KR101317531B1 (ko) 신규한 이미다졸 유도체 및 이를 이용한 유기전자소자
EP1309577A2 (en) Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
CN113845509B (zh) 吲哚基取代螺[环丁烷-1,1′-茚]类化合物的合成方法
NZ509455A (en) Benzenesulfonamide compounds, a process for their preparation and pharmaceutical compositions containing them
CN101914056A (zh) 一种n-烷基取代四氢咔唑酮衍生物的制备方法
CN106432208B (zh) 氨基二硫代甲酸(氨磺酰基)乙酯类化合物及其制备方法和用途
CN110590788A (zh) 一种2-酰基-9H-吡咯并[1,2-a]吲哚类化合物的合成方法
CN103030627B (zh) 一种噻吩环/呋喃环‑杂芳环结构的合成方法
KR20130083887A (ko) 새로운 이미다졸 유도체 및 이를 이용한 유기전자소자